‘A True Seat At The Table’ – Irish Industry Leader Sets Out Aspirations For New Pricing Deal

Teva’s Paul Neill, Chair Of Medicines For Ireland, Talks About Priorities For 2025 Agreement

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.